Resources

Publications

01/22/2023
- Oncology
Genomic and immune landscape of ERBB2/ERBB3 alterations in Gastroesophageal Adenocarcinoma
ASCO Gastrointestinal Cancers Symposium 2023
01/22/2023
- Oncology
Real-world outcome analysis of patients with advanced gastric and gastroesophageal adenocarcinoma with HER2-low expression treated with first-line therapy
ASCO Gastrointestinal Cancers Symposium 2023
01/22/2023
- Oncology
Comprehensive characterization of KRAS mutations and inter-relation with primary tumor location in colorectal cancers
ASCO Gastrointestinal Cancers Symposium 2023
01/22/2023
- Oncology
Characterizing the genomic landscape of POLE/POLD1-mutated colorectal adenocarcinoma
ASCO Gastrointestinal Cancers Symposium 2023
01/22/2023
- Oncology
Prospective BASECAMP-1 experience in patients with gastrointestinal (GI) cancer: Identifying patients with human leukocyte antigen (HLA) loss of heterozygosity (LOH) for a future therapeutic trial exploiting LOH as a tumor vulnerability
ASCO Gastrointestinal Cancers Symposium 2023
01/18/2023
- Oncology
Actionable Genomic Landscapes From a Real-World Cohort of Urothelial Carcinoma Patients
Urologic Oncology: Seminars and Original Investigations
12/11/2022
- Oncology
Gene Expression and Mutation Profiles in HER2-Mutated Metastatic Breast Cancer
San Antonio Breast Cancer Symposium (SABCS) 2022
12/11/2022
- Oncology
The Mutational Landscape of 1172 Patients with Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer Treated with CDK4/6 Inhibitors
San Antonio Breast Cancer Symposium (SABCS) 2022
12/11/2022
- Oncology
Genomic Landscape of Er+/HER2-Metastatic Breast Cancer as a Function of Prior Treatment With a CDK4/6 Inhibitor
San Antonio Breast Cancer Symposium (SABCS) 2022
12/11/2022
- Oncology
Dual ctDNA and Tissue Sequencing Improves Detection of Actionable Variants in Patients With Breast Cancer
San Antonio Breast Cancer Symposium (SABCS) 2022

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31